Open AccessChemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience
Author(s) -
Casey J. Allen,
Alisa N. Blumenthaler,
Grace L. Smith,
Prajnan Das,
Bruce D. Minsky,
Mariela A. Blum,
Jaffer A. Ajani,
Paul F. Mansfield,
Naruhiko Ikoma,
Brian D. Badgwell
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-08864-1
Subject(s) - medicine , surgical oncology , adenocarcinoma , confidence interval , propensity score matching , stage (stratigraphy) , chemotherapy , neoadjuvant therapy , cancer , surgery , breast cancer , paleontology , biology
We compared oncologic outcomes of patients who received neoadjuvant chemotherapy (CT) with those of patients who received neoadjuvant chemotherapy plus chemoradiation (CRT) for resectable gastric adenocarcinoma.